Novartis AG (NVS) – Bullish Recovery with Key Levels to WatchAnalysis Overview:
Novartis AG has shown a strong recovery, bouncing back from its recent low near $91.84, a key support level that held well. The stock is now trading at $103.29 (+3.32%), approaching its mid-term moving averages, signaling renewed momentum.
Key Levels:
Support: $91.84 (Strong bas
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
10,825 ARS
11.94 T ARS
50.30 T ARS
1.69 B
About Novartis AG
Sector
Industry
CEO
Vasant Narasimhan
Website
Headquarters
Basel
Founded
1996
ISIN
ARDEUT112521
FIGI
BBG000PM0JX5
Novartis AG is a holding company, which engages in the business of developing, manufacturing, and marketing healthcare products. It operates through the following segments: Innovative Medicines, Sandoz, and Corporate. The Innovative Medicines segment includes researching, distributing and selling patented pharmaceuticals. The Sandoz segment focuses on marketing finished dosage form medicines and intermediary products including active pharmaceutical ingredients. The Corporate segment is involved in group management and central services. The company was founded on February 29, 1996 and is headquartered in Basel, Switzerland.
Related stocks
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
XPNC
Novartis Capital Corp. 3.0% 20-NOV-2025Yield to maturity
7.16%
Maturity date
Nov 20, 2025
NVS6224266
Novartis Capital Corp. 5.3% 05-NOV-2055Yield to maturity
5.37%
Maturity date
Nov 5, 2055
US66989HAS7
Novartis Capital Corp. 2.75% 14-AUG-2050Yield to maturity
5.34%
Maturity date
Aug 14, 2050
NVS5894401
Novartis Capital Corp. 4.7% 18-SEP-2054Yield to maturity
5.33%
Maturity date
Sep 18, 2054
XPND
Novartis Capital Corp. 4.0% 20-NOV-2045Yield to maturity
5.31%
Maturity date
Nov 20, 2045
US66989HAH1
Novartis Capital Corp. 4.4% 06-MAY-2044Yield to maturity
5.30%
Maturity date
May 6, 2044
NVS6224265
Novartis Capital Corp. 5.2% 05-NOV-2045Yield to maturity
5.28%
Maturity date
Nov 5, 2045
NVS3904288
Novartis Capital Corp. 3.7% 21-SEP-2042Yield to maturity
5.18%
Maturity date
Sep 21, 2042
NVS6224264
Novartis Capital Corp. 4.6% 05-NOV-2035Yield to maturity
4.69%
Maturity date
Nov 5, 2035
NVS5894400
Novartis Capital Corp. 4.2% 18-SEP-2034Yield to maturity
4.50%
Maturity date
Sep 18, 2034
NVS6224263
Novartis Capital Corp. 4.3% 05-NOV-2032Yield to maturity
4.38%
Maturity date
Nov 5, 2032
See all NVS bonds
Curated watchlists where NVS is featured.


